Generex Biotechnology Announces First-in-Human Clinical Trial of the ALTuCELL Cellular Therapy Product Altsulin® (Microencapsulated Sertoli Cells)

NEXT STORY
Beroni Group to Hold the Third Precision Medicine & Medical Care and Aging International Forum (with Conference Theme “Innovation Driving Development, Technology Leading Future”) in Tianjin, China on December 7-8, 2019
PREV STORY
Philips launches next-generation vital signs monitor for early patient intervention in general care setting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Prothena Announces Appointment of Tran B. Nguyen as Chief Operating Officer

DUBLIN, Ireland, June 25, 2018 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a clinical-stage ...

author_avatar
NASDAQ Market News

Amicus Therapeutics Completes Enrollment in ESSENCE Phase 3 Epidermolysis Bullosa Clinical Study

Target Exceeded with More than 160 Patients Enrolled Top-Line Data on Track for 3Q17 ...

author_avatar
NASDAQ Market News

Novartis to divest the Sandoz US dermatology business and generic US oral solids portfolio to Aurobindo

Novartis to focus Sandoz division in US on higher growth areas and will sell ...

author_avatar
NASDAQ Market News